HAE - HAE ヘモネティクス （）

Haemonetics surpassed sell-side expectations with healthy revenue growth from Plasma and Hospital. Read why I think HAE stock merits a closer look.

Haemonetics Corporation (NYSE:NYSE:HAE) Q3 2023 Earnings Conference Call February 7, 2023 8:00 AM ETCompany ParticipantsDavid Trenk - Manager, Investor RelationsChris Simon - Chief…

Haemonetics continues to catch a strong bid in FY23'' having clipped a 74% gain over the past 12 monts. See why we reiterate buy on HAE stock.

The following slide deck was published by Haemonetics Corporation in conjunction with this event.

The Plasmapheresis Machines research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company

The Plasmapheresis Machines research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company

Haemonetics Corporation (NYSE:NYSE:HAE) Q2 2023 Earnings Conference Call November 7, 2022 8:00 a.m.

Financial release accessible online BOSTON , Nov. 7, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that financial results for its second quarter fiscal 2023, which ended October 1, 2022 , are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2022 . The conference call and webcast can be accessed with the following … Full story available on Benzinga.com

Haemonetics (HAE) is scheduled to announce Q2 earnings results on Sunday, November 6th, before market open.The consensus EPS Estimate is $0.67 (+11.7% Y/Y) and the consensus…

Victory Capital Management Inc. grew its position in Haemonetics Co. by 808.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 377,252…

BOSTON, Aug. 23, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022, at 8:45 a.m. ET. The public may access Mr. Simon''s…

Mark W Kroll , Director at Haemonetics (NYSE: HAE ), reported a large insider sell on August 16, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Kroll sold 8,016 shares of Haemonetics . The total transaction amounted to $590,859. Haemonetics shares are trading down 0.72% at $75.77 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com

Haemonetics Corporation (NYSE:NYSE:HAE) Q1 2023 Earnings Conference Call August 10, 2022 08:00 AM ET Company Participants Olga Guyette - Director, IR and Treasury Chris Simon - CEO James…

Haemonetics (NYSE: HAE ) reported its Q1 earnings results on Wednesday, August 10, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Earnings Haemonetics beat estimated earnings by 13.73%, reporting an EPS of $0.58 versus an … Full story available on Benzinga.com

Companies Reporting Before The Bell • Wix.com (NASDAQ: WIX ) is estimated to report earnings for its second quarter. • Xeris Biopharma Holdings (NASDAQ: XERS ) is expected to report earnings for its second quarter. • BiomX (AMEX: PHGE ) is likely to report earnings for its second quarter. • CSP (NASDAQ: CSPI ) is likely to report earnings for its third quarter. • Herbalife Nutrition (NYSE: HLF ) is projected to report quarterly earnings at $0.32 per share on revenue of $329.94 million. • Evaxion Biotech (NASDAQ: EVAX ) is likely to report earnings for its second quarter. • iShares Gold Trust Shares of the iShares Gold Trust (NYSE: IAU ) is likely to report earnings for its second quarter. • Innovid (NYSE: CTV ) is estimated to report quarterly loss at $0.03 per share on revenue of $33.33 million. • Vita Coco (NASDAQ: COCO ) is projected to report quarterly earnings at $0.08 per share on revenue of $115.02 million. • NextNav (NASDAQ: NN ) is likely to report quarterly loss at $0.10 per share on revenue of $1.